Luis Álvarez‐Vallina
- Molecular Biology top 5%
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Immunology top 5%
- Genetics top 5%
- Co-authors
- Laura SanzMarta CompteÁngel M. CuestaBelén BlancoAna Álvarez‐CienfuegosIrene Guijarro-MuñozDavid Sánchez‐MartínRobert E. Hawkins
- Topics
- Monoclonal and Polyclonal Antibodies Research (51 papers)CAR-T cell therapy research (42 papers)Virus-based gene therapy research (17 papers)
- Partner nations
- SpainDenmarkUnited States
In The Last Decade
Luis Álvarez‐Vallina
89 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.5k
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 943
- Immunology 785
- Genetics 373
Countries citing papers authored by Luis Álvarez‐Vallina
This map shows the geographic impact of Luis Álvarez‐Vallina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Álvarez‐Vallina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Álvarez‐Vallina more than expected).
Fields of papers citing papers by Luis Álvarez‐Vallina
This network shows the impact of papers produced by Luis Álvarez‐Vallina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Álvarez‐Vallina. The network helps show where Luis Álvarez‐Vallina may publish in the future.
Co-authorship network of co-authors of Luis Álvarez‐Vallina
This figure shows the co-authorship network connecting the top 25 collaborators of Luis Álvarez‐Vallina. A scholar is included among the top collaborators of Luis Álvarez‐Vallina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Álvarez‐Vallina. Luis Álvarez‐Vallina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 5 | |
| 6 | 65 | |
| 7 | 12 | |
| 8 | 43 | |
| 9 | 31 | |
| 10 | 15 | |
| 11 | 23 | |
| 12 | 18 | |
| 13 | 22 | |
| 14 | 8 | |
| 15 | 11 | |
| 16 | 153 | |
| 17 | 30 | |
| 18 | 2 | |
| 19 | 3 | |
| 20 | 44 |
About Luis Álvarez‐Vallina
Luis Álvarez‐Vallina is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology and Allergy, having authored 93 papers that have together received 2.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (51 papers), CAR-T cell therapy research (42 papers) and Virus-based gene therapy research (17 papers). The work is most often cited by research in Oncology (1.2k citations), Radiology, Nuclear Medicine and Imaging (943 citations) and Immunology (785 citations). Luis Álvarez‐Vallina has collaborated with scholars based in Spain, Denmark and United States. Frequent co-authors include Laura Sanz, Marta Compte, Ángel M. Cuesta, Belén Blanco, Ana Álvarez‐Cienfuegos, Irene Guijarro-Muñoz, David Sánchez‐Martín, Robert E. Hawkins, Jaume Bonet and Rocío Navarro. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.